Clinical Trials
668 trialsESPB
Alexandria University
Bioequivalence Study of Liposomal Doxorubicin 20 mg/10 mL (Doxopeg® vs Caelyx®) in Advanced Cancer Patients
Zodiac Produtos Farmaceuticos S.A.
SENO 3D
University Hospital, Montpellier
NACAGEP
Universitair Ziekenhuis Brussel
MATADOR
Institut Claudius Regaud
Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors
Wake Forest University Health Sciences
EDU-INT-BC
Instituts Supérieurs des Professions Infirmières et Techniques de Santé, Morocco
Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer
Beijing Wehand-Bio Pharmaceutical Co., Ltd
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
National Institutes of Health Clinical Center (CC)
Risk Communication Within Mexican-American Families
National Institutes of Health Clinical Center (CC)
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer
Ono Pharmaceutical Co., Ltd.
PROMESSE
Institut du Cancer de Montpellier - Val d'Aurelle
Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study
Ohio State University Comprehensive Cancer Center
Breast Cancer Education to Prisoner Women
Hitit University
QT-RIBRATING
CMC Ambroise Paré
The Effects of Light Therapy to Treat Cancer-related Side Effects
Reykjavik University
Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region
Pfizer
TREC
Medical University of South Carolina
Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC
Pfizer
A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)
Pfizer
ROSIE
Pfizer
The Effect of Walking and Grounding in Women With Breast Cancer
Ankara University
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study
National Institutes of Health Clinical Center (CC)
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
National Institutes of Health Clinical Center (CC)
ELOCS
University Hospital, Toulouse
A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer
Novartis
Adaptation of a Values Assessment Tool
UNC Lineberger Comprehensive Cancer Center
BRCA Mutations in Latinas
National Institutes of Health Clinical Center (CC)
Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis
National Institutes of Health Clinical Center (CC)
IMCAN
University of Sunderland
Different Resistance Training Intensity Prescription and Monitoring Methodologies: Effects on Strength, Body Composition, and Well-being in Survivors of Breast Cancer
Universidad de Almeria
Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors
Indiana University
SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery
SURGE Therapeutics
NEURO-BREAC
University Hospital Schleswig-Holstein
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
AstraZeneca
MINIVAB
Radboud University Medical Center
HER Image
Amsterdam UMC, location VUmc
CairnSurgical Breast Cancer Locator (BCL) Post-Market Study
CairnSurgical, Inc.
A Clinical Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy Subjects
Shandong Suncadia Medicine Co., Ltd.
Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer
Mayo Clinic
ORCHID
Fudan University
Assessment of the Effect of Probiotic Supplementation on Proinflammatory Mechanisms Induced by Systemic Treatment in Women With Breast Cancer
Poznan University of Medical Sciences
Vaccination With Flt3L, Radiation, and Poly-ICLC
Icahn School of Medicine at Mount Sinai
TIBET
Borstkanker Onderzoek Groep
Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors
Carnegie Mellon University
A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer
SCRI Development Innovations, LLC
SCEMAM
University of Pittsburgh
A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer
Eisai Inc.
BCRL-SSR
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer
Integro Theranostics